Home > Node > Subnode Thiazolidinediones Scheen, A.J.; Paquot, N.; Letiexhe, M.R.; Lefèbvre, P.J. Journees Annuelles de Diabetologie de l'Hotel-Dieu 1999: 213-2291999ISSN/ISBN: 0075-4439 PMID: 10732419 Document Number: 511756 Document emailed within 1 workday Purchase for $29.90 Secure & encrypted paymentsRelated DocumentsKobayashi, M.; Ueki, K. 2015: Thiazolidine, thiazolidinediones, TZD Nihon Rinsho. Japanese Journal of Clinical Medicine 73(3): 402-408Meier, C.; Bodmer, M.; Meier, C.R.; Kraenzlin, M.E. 2009: Thiazolidinediones and skeletal health Revue Medicale Suisse 5(207): 1309Schmitz, O.E.; Brock, B.; Madsbad, S.; Beck-Nielsen, H. 2001: Thiazolidinediones--a new class of oral antidiabetics Ugeskrift for Laeger 163(44): 6106-6111Ovalle, F.; Fernando, O.-B.úm.J. 2002: Thiazolidinediones: a review of their benefits and risks Southern Medical Journal 95(10): 1188-1194Braunstein, S. 2003: Cardiovascular disease and benefits of thiazolidinediones Postgraduate Medicine Spec No: 45-52Camp, H.S. 2003: Thiazolidinediones in diabetes: current status and future outlook Current Opinion in Investigational Drugs 4(4): 406-411Bozdağ, O.; Verspohl, E.J.; Ertan, R. 2000: Synthesis and hypoglycemic activity of some new flavone derivatives. 3rd communication: 3'-flavonyl-2,4-thiazolidinediones Arzneimittel-Forschung 50(7): 626-630Weigert, C.; Brodbeck, K.; Bierhaus, A.; Häring, H.U.; Schleicher, E.D. 2003: c-Fos-driven transcriptional activation of transforming growth factor beta-1: inhibition of high glucose-induced promoter activity by thiazolidinediones Biochemical and Biophysical Research Communications 304(2): 301-307